Table 3.
All Men* |
Men Meeting Entry Criteria† |
|||
---|---|---|---|---|
Variable | Adjusted RR (95% CI) | p Value | Adjusted RR (95% CI) | p Value |
Age at diagnosis | 1.056 (1.013, 1.1) | 0.011 | 1.078 (1.022, 1.137) | 0.006 |
PSA at diagnosis | 0.972 (0.893, 1.059) | 0.52 | 1.023 (0.892, 1.173) | 0.745 |
PSA density at diagnosis/0.01 U change | 1.027 (0.992, 1.063) | 0.135 | 1.109 (1.011, 1.217) | 0.029 |
PSA slope‡ | 1.207 (0.991, 1.469) | 0.061 | 1.274 (1.037, 1.565) | 0.021 |
No. Ca pos cores | 1.192 (0.811, 1.753) | 0.371 | 1.182 (0.631, 2.212) | 0.602 |
Max % core involvement with Ca | 1.009 (0.997, 1.022) | 0.141 | 1.015 (0.996, 1.033) | 0.118 |
Diagnosis yr | 0.881 (0.816, 0.951) | 0.001 | 0.874 (0.799, 0.956) | 0.003 |
Total of 351 patients, including 87 with delayed curative intervention and 264 untreated.
Total of 288 patients, including 70 with delayed curative intervention and 218 untreated.
Regression of PSA on time using all PSA values after cancer diagnosis.